New York City Metropolitan Area
Health services researcher | former biopharma professional | expertise in cancer outcomes, health equity, qualitative research, FDA regulatory policy, HEOR/RWE & healthcare analytics.
Lead multi-site clinical and social-behavioral research projects focused on breast cancer, overseeing study design, IRB submissions, on site implementation, and scientific writing for peer-reviewed publications. Support community outreach and engagement initiatives to promote equitable access to cervical cancer screening and prevention across diverse populations.
Co-led and managed large-scale qualitative research on FDA’s drug approval standards and postmarketing studies in cancer and rare diseases, conducting data analysis and leading manuscript development.
Supported research initiatives to optimize clinical outcomes assessments, including refining established patient-reported outcome measures and creating a comprehensive library of commonly used tools. Collaborated with external research partners to ensure project quality, advanced publication efforts, and engaged with cancer patients/advocacy groups to integrate patient perspectives into observational studies.
Directed initiatives to drive company growth by identifying new business opportunities. Led ally-building efforts, including media outreach, to foster collaborations with healthcare experts, and established the IMS Institute agenda to develop academic alliances and advance healthcare research projects.
Led the development and launch of prescription data-based offerings for South Korea. Managed cross-functional task force teams to ensure successful product development and supported company-wide marketing initiatives post-launch to drive adoption and impact.
Directed two Medical Education business units, overseeing projects for over 15 biopharmaceutical companies. Led strategic planning to enhance service offerings and provided guidance on business pitches and medical communication proposals.